Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
73M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
52.5M
-
Shares change
-
-4.91M
-
Total reported value, excl. options
-
$114M
-
Value change
-
-$11.8M
-
Put/Call ratio
-
2.35
-
Number of buys
-
59
-
Number of sells
-
-48
-
Price
-
$2.18
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q3 2024
137 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.5M shares
of 73M outstanding shares and own 71.85% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (6.72M shares), BlackRock, Inc. (4.91M shares), CITADEL ADVISORS LLC (4.46M shares), VANGUARD GROUP INC (3.47M shares), FARALLON CAPITAL MANAGEMENT LLC (3.17M shares), TANG CAPITAL MANAGEMENT LLC (3.1M shares), Octagon Capital Advisors LP (2.39M shares), Redmile Group, LLC (2.11M shares), Sio Capital Management, LLC (1.97M shares), and GOLDMAN SACHS GROUP INC (1.94M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.